News
First canine patient receives Vetigenics’ fully canine anti-CTLA4 monoclonal antibody for oral melanoma
November 7, 2023
Two fully funded pilot studies to treat cancer free for pet owners who bring their dogs to research sites. PHILADELPHIA,...
Read More
Vetigenics’ Canibody platform attracting more potential collaborators
June 30, 2023
US pet therapeutics start-up Vetigenics is seeing increased interest from potential collaborators in its Canibody. Adriann Sax, the co-founder and...
Read More
Enhancing Canine Wellness: The Promise of Immunotherapy for Dogs
June 9, 2023
Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find...
Read More
Vetigenics Announces Second Discovery Collaboration with a Major Animal Health Pharma
November 8, 2022
New partnership established to explore multiple novel therapeutic antibodies for treating challenging pet diseases. Read More
Read More
Vetigenics Announces Publication of Comprehensive Preclinical Data for Anti-Canine CTLA4 Monoclonal Antibody
January 5, 2022
Published study confirms validity of the first entirely canine phage display technology to generate unique canine immunotherapy for treating canine...
Read More
Vetigenics Receives Startup of the Year Award from Penn Center for Innovation
December 3, 2021
Successful creation of the first entirely canine phage display platform for research and development of antibody immunotherapy spurs recognition for...
Read More
Vetigenics Announces Discovery Collaboration With Merck Animal Health
November 2, 2021
Partnership extended to explore multiple novel therapeutic antibodies for treating challenging pet diseases PHILADELPHIA, Nov. 2, 2021 /PRNewswire/ -- VETIGENICS,...
Read More
Animal Health Innovation USA | Virtual Event
June 16, 2021
Please join us on June 16 at 12:45pm to learn more about Vetigenics as a Innovation Showcase Finalist at the...
Read More
Vetigenics Aims to Solve Challenges in Canine Immunotherapy Discovery and Development
July 21, 2020
Adriann Sax has been appointed to advance Vetigenics from an academic start-up to an independent animal health biotech company. Ms...
Read More
An Interview with Adriann Sax, Biotech Executive & Entrepreneur
June 18, 2020
This week, Jason Colodne, Managing Partner at Colbeck, spoke with Adriann Sax, co-founder and CEO at Vetigenics, a prominent innovator...
Read More